Medplus Health Services Q2 FY27 Results: Profit Dip in Focus

Track the latest Medplus Health Services Ltd. share price on Univest.

Medplus Health Services Q2 results for the September 2026 quarter are drawing early attention from investors in the pharmacy retail chain, especially after a sharp profit dip in the previous quarter. This preview builds the Medplus Health Services Q2 results discussion strictly from reported, historical quarterly numbers, not from any invented date or estimate.

Medplus Health Services Q2 Results Date

No official date for the Medplus Health Services Q2 results has been announced yet. Indian listed companies typically report September-quarter (Q2 FY27) numbers across October and November, after the board approves the quarterly financials. Until Medplus Health Services Ltd. makes a formal exchange filing, no confirmed date exists for the Medplus Health Services Q2 results, and readers should check NSE and BSE disclosures directly for the final schedule.

Medplus Health Services Q2 Results Expectations

Medplus Health Services Q2 Results Expectations center on one clear data point from the last reported quarter: operating margin fell to 7.07% in Jun26 from 9.07% in Mar26, and net profit dropped to Rs 33 crore from Rs 64 crore over the same period, even as revenue kept rising to Rs 1,880 crore. This Jun26 notable profit decline (net profit of Rs 33 crore versus Rs 64 crore in Mar26) despite sales growth, with OPM dropping to 7.07% from 9.07%, is the single biggest factor shaping Medplus Health Services Q2 Results Expectations this cycle. Whether the Medplus Health Services Q2 results show margin stabilising back toward the 8 to 9% band seen through most of the last five quarters, or continuing to compress, is the open question. Store network expansion and revenue growth have been consistent, so the Medplus Health Services Q2 results will likely be read primarily through the margin and profit lens rather than the topline.

Also read – Dabur India Q2 Results FY27 Preview

Previous Quarter (Q1 FY27, Jun26) Performance

In Jun26 (Q1 FY27), Medplus Health Services reported revenue of Rs 1,880 crore, operating profit of Rs 133 crore, an OPM of 7.07%, and net profit of Rs 33 crore. Revenue edged up marginally from Rs 1,864 crore in Mar26, but both operating profit and net profit fell well short of the Mar26 print of Rs 169 crore and Rs 64 crore respectively. This divergence between steady sales and weaker profitability is the immediate backdrop heading into the Medplus Health Services Q2 results.

Q2 FY26 (Sep25) Base Quarter

The year-ago base for the Medplus Health Services Q2 results is Sep25 (Q2 FY26), when the company reported revenue of Rs 1,679 crore, operating profit of Rs 149 crore, OPM of 8.87%, and net profit of Rs 56 crore. Once the Medplus Health Services Q2 results are announced, the year-on-year comparison will be measured against this Sep25 base, including the 8.87% OPM and Rs 56 crore net profit figures.

Recent Trend: Jun25 Through Jun26

The five-quarter run shows steady revenue growth alongside a recent profit wobble. Revenue moved from Rs 1,543 cr (Jun25) to Rs 1,679 cr (Sep25) to Rs 1,806 cr (Dec25) to Rs 1,864 cr (Mar26) and Rs 1,880 cr (Jun26), rising in every quarter. OPM, however, moved from 8.49% to 8.87% to 8.8% to 9.07% and then fell to 7.07% in the most recent quarter. Net profit similarly climbed from Rs 42 cr to Rs 56 cr to Rs 58 cr to Rs 64 cr before dropping to Rs 33 cr in Jun26. This break in an otherwise consistent margin and profit uptrend is the key context ahead of the Medplus Health Services Q2 results, and it is the single biggest swing factor separating this quarter's Medplus Health Services Q2 results from the four quarters that preceded it.

Key Factors to Watch in Medplus Health Services Q2 Results

Three themes stand out ahead of the Medplus Health Services Q2 results. First, whether the Jun26 margin compression to 7.07% was a one-quarter event tied to store expansion costs or the start of a new, lower margin band. Second, revenue has grown every single quarter from Rs 1,543 crore to Rs 1,880 crore, and continued store additions in the pharmacy retail network remain a structural growth driver independent of any single quarter's Medplus Health Services Q2 results. Third, a debt-to-equity ratio of 0.72 means the balance sheet carries moderate debt levels relative to some peers, which is worth factoring in alongside the profit numbers.

Valuation Ahead of Medplus Health Services Q2 Results

Also read – Dalmia Bharat Q2 Results FY27 Preview

At a CMP of Rs 663.05, Medplus Health Services Ltd. trades at a trailing PE of 37.76 and a price-to-book (PB) of 4.02, against a book value of Rs 165 per share and an EPS of Rs 17.56. Return on equity stands at 11.6% and the debt-to-equity ratio is 0.72. Market capitalisation is around Rs 7,962 crore, and the stock does not currently pay a dividend. These figures form the base against which any updated valuation will be recalculated once the Medplus Health Services Q2 results are announced and trailing earnings are refreshed.

What to Watch in Medplus Health Services Q2 Results

Ahead of the Medplus Health Services Q2 results, three things merit attention. One, whether OPM recovers toward the 8 to 9% range of Sep25 through Mar26 or stays closer to the Jun26 level of 7.07%. Two, whether revenue growth, which has not slowed in five straight quarters, continues at a similar pace into the September 2026 quarter. Three, how the stock behaves technically, currently trading below its 50-day moving average of Rs 690.46 and well below its 200-day moving average of Rs 805.98, with an RSI of 51.76. These are observations drawn from historical data, not predictions about the Medplus Health Services Q2 results themselves.

Investors tracking Medplus Health Services Ltd. and other pharmacy retail names can open a demat account with Univest here: https://univest.in/open-demat-account.

Conclusion

The Medplus Health Services Q2 results for the quarter ended September 2026 have not been announced yet, and no date, estimate or forecast has been assumed in this preview. The most important thread carried into this results season is the Jun26 profit decline, with net profit at Rs 33 crore against Rs 64 crore in Mar26 and OPM at 7.07% against 9.07%, even as revenue kept climbing to Rs 1,880 crore. That tension between rising sales and softer margin is exactly what the Medplus Health Services Q2 results will need to address.

To get notified the moment Medplus Health Services Ltd. confirms its results date, create a free Univest account: https://univest.in/open-demat-account.

Track pharmacy retail stocks and more ahead of the Medplus Health Services Q2 results by opening a Univest demat account: https://univest.in/open-demat-account.

This article is prepared for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Historical financial figures are based on publicly available quarterly filings and may be subject to revision; no results date, estimate, or forecast for the upcoming quarter has been stated or implied by Univest. Investments in securities are subject to market risk, and readers should consult a SEBI-registered investment advisor before making any investment decision. Univest Research (SEBI Registration No. INH000013776) is not liable for the accuracy of third-party data referenced above.

When will Medplus Health Services Q2 results be announced?

Ans. No official date for the Medplus Health Services Q2 results has been announced yet. Companies typically report September-quarter (Q2 FY27) numbers across October and November, and readers should check NSE or BSE filings for confirmation.

Why did Medplus Health Services profit fall in the previous quarter (Jun26)?

Ans. Jun26 showed a notable profit decline, with net profit of Rs 33 crore versus Rs 64 crore in Mar26, despite sales growth, and OPM dropped to 7.07% from 9.07%.

How did Medplus Health Services perform in Q2 FY26 (Sep25), the base quarter?

Ans. In Sep25 (Q2 FY26), the company reported revenue of Rs 1,679 crore, operating profit of Rs 149 crore, OPM of 8.87%, and net profit of Rs 56 crore.

What is Medplus Health Services' valuation ahead of Q2 results?

Ans. At a CMP of Rs 663.05, Medplus Health Services Ltd. trades at a trailing PE of 37.76 and a price-to-book (PB) of 4.02, with a return on equity of 11.6% and a debt-to-equity ratio of 0.72.